PIRIMS - Operations Manual Ver. 1.1 - Pharmaceutical Company

Operations Manual – Pharmaceutical Company
Drug Regulatory Authority of Pakistan

(DRAP)
Pakistan
Integrated
Regulatory
Information
Management
System
(PIRIMS)
Pakistan Integrated Regulatory Information Management System (PIRIMS)
DOCUMENT INFORMATION
Category Information
Customer Drug Regulatory Authority of Pakistan (DRAP)
Pakistan Integrated Regulatory Information Management System
Project
(PIRIMS)
Document PIRIMS – Operations Manual
Document Version 1.1
Classification level Submission
Identifier DRAP-PIRIMS-Operations Manual-02
Author(s) Muhammad Asghar, USP /DRAP Software Consultant
Approver(s) Drug Regulatory Authority of Pakistan (DRAP) /USP
Issue Date 26-Nov-2020
1. Drug Regulatory Authority of Pakistan (DRAP)
Distribution 2. United States Pharmacopeial Convection (USP)
3. All Pharmaceutical Companies of Pakistan
DOCUMENT REVIEW INFORMATION
Review Date Reviewer Name Version Reference / Evidence
DOCUMENT REVISION HISTORY
Author Date Version Description (Change made, Sec Ref, CR#)

M. Asghar 30-Oct-2020 1.1 Modification based on DRAP and
Pharmaceutical Industry Training
feedback.
Copyright  Drug Regulatory Authority of Pakistan (DRAP) - All rights reserved i

Unauthorized copy or use of this document is strictly prohibited
DEFINITION OF TERMS, ACRONYMS AND ABBREVIATIONS
Term Description
ATC Anatomical Therapeutic Chemical
CAPA Corrective And Preventive Action
CDL Central Drug Lab
cGMP Current Good Manufacturing Practices
CLB Central Licensing Board
CoPP Certificate of Pharma Products
CTD Common Technical Documentation
DML Drug Manufacturing License
DRB Drug Registration Board
DSL Drug Sale License
DTL Drug Testing Lab
eCTD Electronic Common Technical Documentation
FDA Food & Drug Administration
FID Federal Inspector of Drugs
FSC Free Sale Certificate
GDP Generic Drug Product
GMP Good Manufacturing Practices
INN International Nonproprietary Name
LASA Looks-Alike, Sounds-Alike
LT Lab Testing
MoM Minutes of Meeting
NDP New Drug Product
PIRIMS Pakistan Integrated Regulatory Information Management System
PV Pharmacovigilance
QA Quality Assurance
QC Quality Control
SmPC Summary of Product Characteristics
USP United State Pharmacopeia
WHO World Health Organization
Copyright  Drug Regulatory Authority of Pakistan (DRAP) - All rights reserved ii

Figure # Figure Name Page #
Copyright  Drug Regulatory Authority of Pakistan (DRAP) - All rights reserved iii
LIST OF TABLES
Table # Table Name Page #
Copyright  Drug Regulatory Authority of Pakistan (DRAP) - All rights reserved iv

LIST OF APPENDICES
Appendix # Appendix Name Page #
Copyright  Drug Regulatory Authority of Pakistan (DRAP) - All rights reserved v

Table of Contents
OPERATIONS MANUAL – PHARMACEUTICAL COMPANY ....................................................... 1

DRUG REGULATORY AUTHORITY OF PAKISTAN (DRAP) ..................................................... 1
DOCUMENT INFORMATION ....................................................................................... I
DOCUMENT REVIEW INFORMATION ............................................................................. I
DOCUMENT REVISION HISTORY ................................................................................ I
DEFINITION OF TERMS, ACRONYMS AND ABBREVIATIONS .....................................................II
LIST OF TABLES .................................................................................................. IV
LIST OF APPENDICES ............................................................................................. V
1. Introduction ...............................................................................................1
2. Project Overview .........................................................................................1
2.1.1. Client, Customer and other Stake holders .....................................1
2.1.2. Users /Roles..............................................................................1
3. PIRIMS, a kick-start ....................................................................................2
3.1. Pre-requisites ......................................................................................2
3.2. Login Interface ....................................................................................2
3.3. Licensing Module ............................................................................... 10
3.3.1. New License (Company User) .................................................... 10
3.3.2. License Renewal (Company User) .............................................. 18
3.3.3. Post License Changes (Company User) ....................................... 19
3.4. Registration Module ........................................................................... 21
3.4.1. New Registration (Company User) ............................................. 21
3.4.2. Registration Renewal (Company User) ........................................ 26
3.4.3. Post Registration Changes (Company User) ................................ 27
3.5. Inspection Module .............................................................................. 28
4. Credentials for PIRIMS ............................................................................... 30
5. Support ................................................................................................... 31
Copyright  Drug Regulatory Authority of Pakistan (DRAP) - All rights reserved vi

1. Introduction
This Operations Manual will demonstrate all types of users with complete flow of
their specific modules /areas using the graphical user interfaces (GUIs). This will be
a kick-start for a novice user to start working on PIRIMS without having much
Information Technology knowledge and education.
2. Project Overview
The basic purpose of this project is to automate various functions and processes
of DRAP into a harmonized and integrated way (PIRIMS) with WHO guidelines and
FDA best practices to let the concerned stakeholder know and monitor their
routine work while giving transparency at all levels to Pharma industry and DRAP
management to evaluate the staff efficiency and quality.
2.1.1. Client, Customer and other Stake holders
Following will be the Software stakeholders:
1. Pharmaceutical Industry of Pakistan
2. Drug Regulatory Authority of Pakistan
3. Drug Testing Labs (DTL)
4. World Health Organization (WHO)
5. United State Pharmacopeia (USP)
2.1.2. Users /Roles
Following will be the core users of this PIRIMS system.
1. Pharma Industry Authorized User
2. Super Admin of PIRIMS
3. Divisional Admin
4. Director of each Concerned Division
5. Additional Director of Each Concerned Division
6. Deputy Director of Each Concerned Division
7. Additional Director of Field office
8. FID of Field Office
9. Assistant Director of Field office
10. Assistant Director of Division
11. CDL authorized user
12. DTL authorized user
13. CEO of DRAP
Copyright  Drug Regulatory Authority of Pakistan (DRAP) - All rights reserved 1

3. PIRIMS, a kick-start
Following are the core modules of Pakistan Integrated Regulatory
Management Information System (PIRIMS):
1. Licensing
2. Registration
3. Inspection
After successful login in PIRMIS, respective user will go to their respective dashboard
as shown below:
• Company User
Company user will go to the following dashboard after successful login:
3.1. Pre-requisites
Since it’s an online web based software system, following needs to be done before
starting working on PIRIMS:
1. Computerized electronic device (PC, Workstation, Laptop, Tablet or Smart-

phone) connected to a reasonable speed of internet.
2. Devices with Windows 10, iOS, Android will be ready to connect this
application.
3. Google Chrome is the preferred browser to get optimum results
3.2. Login Interface

User will open the browser and will type the URL to access the login page of the
application:

This will take the user to the login page of PIRIMS software as shown below in the
figure 1.0.
Figure 1.0
On login interface, user will have the following options:
• User has an option (I forgot my password) to reset the password if user has
forgotten his /her password as shown in figure 1.1
Figure 1.1

User will input the registered email and will also put the security /validation code in
the text box and will press the submit button.
An email with confirmation link will be sent to the provided email account and once
user will click on the link a new email with new password will be sent to the user’s
provided registered email. User then would be able to login by using the new
password and if required, user will also be able to change his /her password from the
PIRIMS software that will be discussed later on.
If user wants to go back to previous login page, he /she can click on the Login link
to go back to the main login page.
• If Pharmaceutical company user is not yet registered in the system, he /she can
use this option to do so as shown below in figure 1.2

Figure 1.2
Basically, this new company registration process is for a pharmaceutical company
who has not yet registered with PIRIMS of Drug Regulatory Authority of Pakistan
(DRAP). Company authorized person will use this option to get his /her company
registered with PIRIMS. Once this registration form is filled along with validation code
and submitted by company user, same application will be available with DRAP Super
Admin user who will then activate the company and at the same point and time a
new company user will be created and login credentials will be sent to the company
user who will then have access to company interface of PIRIMS software system.

• After furnishing the registered email and password, user can log into the PIRIMS
If user has furnished the accurate and registered user email and password, he /she
will be directed to the dashboard /landing page as shown below in figure 2.0
Figure 2.0
Once user is successfully logged into the PIRIMS system, following are the activities
he /she can perform:
• By clicking on the name of the user (right-top of the screen), user can perform the
following two functions as shown below in Figure 2.1 and Figure 2.2:
o Sign out from the PIRIMS
o Profile link to edit basic information of the user
▪ Change Password can also be done from Profile link.

Figure 2.1
Figure 2.2
• User can access the following quick links as shown below in Figure 2.3:
o Lock application screen
o Messages
o Notifications
o Tasks
Figure 2.3
• User can access the PIRIMS functions where he /she has been given rights
/privileges by the admin of the software. These functions can be access by
clicking on the Left Navigation Menu as shown below in Figure 2.4:

Figure 2.4
In the search area, user can find the required function from the navigation menu.
This is ideal feature when a user has access for too many functions and user
wants to access that function quickly. User will type and combination of
characters and system will show the matching option in parallel as user types in.
• Depending on the data, user can expand and collapse the screen by clicking on the
button next to the PIRIMS name on the left top side of the application as shown
below in Figure 2.5 and once Left Navigation is in collapsed mode, it will look
like as shown below in Figure 2.6.

Figure 2.5
Figure 2.6

Figure 2.7
3.3. Licensing Module
Following are all possible license application processing stages:
Draft
Submitted
Screening
Under R and I
Received By DRAP
Under Review Stage 1
Under Inspection
Under Board Stage 2
Referred Back To Company (Editable)
Referred Back To Company (Locked)
Recommended By Board Stage 3
Deferred and Closed
Approved
Mainly there are two parties involved in this flow, 1. The Company and 2. DRAP. Now
we will see the Step-By-Step flow of New License Application using the Graphical
User Interfaces (GUIs) by mentioning the interface owner role against each
interface:
3.3.1. New License (Company User)

Company will open the following interface to initiate the request:
1. From Left Navigation Menu, company user will click on the License link and
will see the following interface as shown in Figure 4.0:

Figure 4.0
Next company user will click on +License to initiate the new License request and
then user will see the following image as shown in Figure 4.1:
Figure 4.1
By default, company user will be on License Category tab, the first page to initiate
the License. In this tab, user will input the License types out of the given type. Fee of
each license is also provided against each type with option to Generate Bank
Voucher that will be paid by the company and signed and stamped copy will be
uploaded as well.
Now Company user will click on the Company Management tab where they will
provide the management details as shown in the following Figure 4.2.

Figure 4.2
User can add new row by clicking on Plus sign and can remove row by clicking on Del
button as shown below:
After Management Tab, Company user will click on Inspection tab to allow user to
input required Site verification schedule.
Figure 4.3
Upon completion of above tab where DRAP has approved the Site Verification
phase, company user will now click on Layout Plan tab of the Licensing interface
and will attach the required Layout plan in PDF format in this section as shown below

in Figure 4.4. User can see the Current Phase of the License application just above
the Save button.
Figure 4.4
Now company user will click on Sections & Machines tab and will input the related
Section Wise Machine Names and other required information in this section and will
move to the next tab as shown below:
Figure 4.5
Next tab would be Drugs & Classes where company user will click and will input the
required details which will be required in Renewal case:
Please see below Figure 4.6 to add above information:

Figure 4.6
Next tab will be for the Qualified Staff as shown in the following figure:
Figure 4.7
PLEASE NOTE:
Last thing on the Inspection form is to input the Fee Invoice No. Please note that at
the time of Site Verification phase, only one fee invoice will be visible and once
verified by online banking system, status of invoice will be shown as Paid. On all
other phases, user will input respective Invoice No. and will save and then submit
the application that will validate the fee from bank and will set the status as Paid
accordingly. This process will be for all phases of the application. Please see same in
the last tab as shown below:

Figure 4.8
Company user may also input remarks in the Applicant’s Remarks section which is
commonly available under all tabs of the form.
Along-with this, there is a list available where applicant can set the Priority of the
application. Same priority will be validated from DRAP as well.
Now finally, can either Save the application as Draft and can edit same again or
user can finally Submit the application to DRAP for next processes and same
application will become Read-Only for the applicant.
Now company user has applied for the Drug Manufacturing License. Now user will
find a newly created record in the Licensing List view interface as shown below:
Figure 4.9

Company user can now monitor the submitted application by checking the Status of
the application. Whatever proceeding is happening to the submitted application,
company user can see from this interface under Status column.

Following License could be generated once application is approved by Director after

CLB recommendations which will be available to Pharmaceutical company:
Figure 4.10

3.3.2. License Renewal (Company User)

For license renewals, company user will see the Renewable Licenses in the
License Renewal as shown below in Figure 4.11.
Figure 4.11
If Renewal application has already been submitted with DRAP then it becomes the
read-only record for the applicant as shown in below image where user tried to edit
the application again but system shows error in red.
Figure 4.12

This listing will be shown automatically based on the pre-set reminders’ frequency.
For example, a company should get a reminder for the Renewal date of the License
before 6 months of the expiry of the License. A record will be shown to the company
user in the License Renewal Listing page as shown above.
Similar flow (Except Phases) will be executed as we saw in New License section of
this Operations Manual.
3.3.3. Post License Changes (Company User)

For Post License Changes of an existing License, company user will click on the Post
License Changes from the Left Navigation Menu. A list view of existing Post
License Changes Listing page will be popped-up. On the top-right side of the
interface, click on +Post License Changes button as shown below in Figure 4.13.
Figure 4.13
Following interface will be opened when you will click on the +Post License
Changes link:

Figure 4.14
Similar flow of Post License Changes will be executed as we saw in New License
section of this Operations Manual except the phases of the licenses (Site Verification,
Layout Plan approval and Grant of DML) as applicant will send the change request of
an existing granted DML.

3.4. Registration Module

Following are all possible stages of registration application:
Draft
Submitted
Screening
Under R and I
Received By DRAP
Review Complete
Under Inspection
Under Board Stage 3
Referred Back To Company (Editable)
Referred Back To Company (Locked)
Recommended By Board Stage 4
Pricing Complete
Deferred and Closed
Approved
In Registration module, flow is initiated by a Pharmaceutical Company and then

DRAP will look into this request and will process the request as per defined SOPs.
Mainly there are two parties involved in this flow, 1. The Company and 2. DRAP. Now
we will see the Step-By-Step flow of Registration Application using the Graphical
User Interfaces (GUIs) by mentioning the interface owner role against each
interface:
3.4.1. New Registration (Company User)

Company will open the following interface to initiate the request:
From Left Navigation Menu, company user will click on the Registration link and
will see the following interface as shown in Figure 5.0:

Figure 5.0
Company user will click on the + Registration button on the top-right corner of the
Registration Listing Page.
Following interface will be shown to the company user as per the following Figure 5.1
Figure 5.1
Company user will input Registration Category tab details where user will select
the required license name and then will select the Registration Type. In Registration
type, there are three types as follows:
1. New Drug Product (NDP)

2. Generic Drug Product (GDP)
3. Drug for Import
If the intended product is based on new molecule in the country then, user will select
the New Drug Product (NDP) and if Innovator product is already in the market
then user will select Generic Drug Product (GDP). If drug is to be import by the
importer, user will select the same category.

Then user will move to Drug Info tab and will input the required information over
there as shown below in Figure 5.2
Figure 5.2
User will input data against all mandatory fields in Drug Info tab to save the record.
If there are multiple INN against a requested drug for registration, separate S-Part
will be entered in the system from the link given against each INN.
Now user will fill the CTD format based data along-with attachment, (if required) in
Document Submission (CTD) tab as shown in below figures:
Figure 5.3

Figure 5.4
To record S-Part, user will use following interface that’s available against INN name
in the Drug Info. Tab:
Figure 5.5
Company user will input the CTD structural data in the CTD data structure and
finally, company user will pay the fee and will input Invoice Number in the last tab
of the Registration application form which will be validated from the bank online
system and based on the confirmation paid fee will be acknowledged by the
system. User will then input remarks and will then Submit the record with Apply
status. Once application is submitted, it will become read-only for the company and
they will not be able to modify the submitted application.
Company user can now monitor the submitted application by checking the Status of
the application. Whatever proceeding is happening to the submitted application,
company user can see from this interface under Status column.
For all types of observations and queries, user can see in the Company
Query section of left navigation menu of PIRIMS.

Upon completion of Pricing, application will go to Director Registration who will

finally approve the registration application and thus registration work is concluded
and now company user can view the registration letter from his /her own
dashboard.
Figure 5.6

3.4.2. Registration Renewal (Company User)

For registration renewals, company user will see the Renewable Registrations in
the Registration Renewal as shown below in Figure 5.7.
Figure 5.7
This listing will be shown automatically based on the pre-set reminders’ frequency.
For example, a company should get a reminder for the Renewal date of the
Registration before 6 months of the expiry of the Registration. A row will be shown to
the company user in the Registration Renewal Listing page as shown above.
Similar flow for company and DRAP will be executed as we saw in New
Registration section of this Operations Manual.

3.4.3. Post Registration Changes (Company User)

For Post Registration Changes of an existing Registration, company user will click on
the Post Registration Changes from the Left Navigation Menu. A list view of
existing Post Registration Changes will be popped-up. On the top-right side of the
interface, click on +Post License Changes button as shown below in Figure 5.8.
Figure 5.8
Figure 5.9
Similar flow for company and DRAP will be executed as we saw in New
Registration section of this Operations Manual.

3.5. Inspection Module
Following are all possible stages for the workflow of inspection:
Draft
Inspection Scheduled
Inspection Pending
Initiated
Inspection Completed
Panel Meeting Scheduled
Panel Meeting Pending
CAPA Awaited From Company
CAPA Received From Company
Review Complete
Further Information Required
Follow-Up Inspection
Re-Inspection
Deferred and Closed
Approved
1. Once inspection is scheduled, company will be notified from PIRIMS about the
inspection schedule and they will upload Site Master File on the PIRIMS software
ahead of time for the auditors to review the attached document before inspection.
Now based on the panel decision, company will be granted GMP certificate or if there
are any Critical, Major or minor issues that were observed during inspection session,
company will be given Corrective And Preventive Action (CAPA) form that they will
have to complete in a stipulated time-frame. In this scenario, CAPA form will be filled
automatically with regard to the observation and will be sent to company by software
itself that company will complete and will send back to DRAP for their verification
process.
Following image will depict the CAPA for the company user that will be based on
Inspection report.

Figure 6.0
Later on, during next assessment /inspection of the company, same CAPA will be
verified by the inspection panel members.
Pharmaceutical company user will be able to get the GMP certificate from the list
view interface of inspections module.

4. Credentials for PIRIMS

User can access PIRIMS from the following URL:
Please ask DRAP for the user credentials to access PIRIMS.

5. Support
For any technical support related to PIRIMS, user can contact the under-signed:
Muhammad Asghar
USP /DRAP Software Consultant
Cell: +92 322 5948778
Email: muhammad.asghar@gmail.com


PIRIMS - Operations Manual Ver. 1.1 - Pharmaceutical Company

Uploaded by

Document Information

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

PIRIMS - Operations Manual Ver. 1.1 - Pharmaceutical Company

Uploaded by

Copyright:

Available Formats

Operations Manual – Pharmaceutical Company

Drug Regulatory Authority of Pakistan

DOCUMENT REVIEW INFORMATION

Review Date Reviewer Name Version Reference / Evidence

DOCUMENT REVISION HISTORY

Author Date Version Description (Change made, Sec Ref, CR#)

Copyright  Drug Regulatory Authority of Pakistan (DRAP) - All rights reserved i

DEFINITION OF TERMS, ACRONYMS AND ABBREVIATIONS

CAPA Corrective And Preventive Action

CDL Central Drug Lab

cGMP Current Good Manufacturing Practices

CLB Central Licensing Board

CoPP Certificate of Pharma Products

CTD Common Technical Documentation

DML Drug Manufacturing License

DRB Drug Registration Board

DSL Drug Sale License

DTL Drug Testing Lab

eCTD Electronic Common Technical Documentation

FDA Food & Drug Administration

FID Federal Inspector of Drugs

FSC Free Sale Certificate

GDP Generic Drug Product

GMP Good Manufacturing Practices

INN International Nonproprietary Name

LASA Looks-Alike, Sounds-Alike

MoM Minutes of Meeting

NDP New Drug Product

PIRIMS Pakistan Integrated Regulatory Information Management System

SmPC Summary of Product Characteristics

USP United State Pharmacopeia

WHO World Health Organization

Copyright  Drug Regulatory Authority of Pakistan (DRAP) - All rights reserved ii

Figure # Figure Name Page #

Table # Table Name Page #

Copyright  Drug Regulatory Authority of Pakistan (DRAP) - All rights reserved iv

Appendix # Appendix Name Page #

Copyright  Drug Regulatory Authority of Pakistan (DRAP) - All rights reserved v

OPERATIONS MANUAL – PHARMACEUTICAL COMPANY ....................................................... 1

Copyright  Drug Regulatory Authority of Pakistan (DRAP) - All rights reserved vi

Copyright  Drug Regulatory Authority of Pakistan (DRAP) - All rights reserved 1

Company user will go to the following dashboard after successful login:

1. Computerized electronic device (PC, Workstation, Laptop, Tablet or Smart-

3.2. Login Interface

Copyright  Drug Regulatory Authority of Pakistan (DRAP) - All rights reserved 2

Copyright  Drug Regulatory Authority of Pakistan (DRAP) - All rights reserved 3

Copyright  Drug Regulatory Authority of Pakistan (DRAP) - All rights reserved 4

Copyright  Drug Regulatory Authority of Pakistan (DRAP) - All rights reserved 5

Copyright  Drug Regulatory Authority of Pakistan (DRAP) - All rights reserved 6

Copyright  Drug Regulatory Authority of Pakistan (DRAP) - All rights reserved 7

Copyright  Drug Regulatory Authority of Pakistan (DRAP) - All rights reserved 8

Copyright  Drug Regulatory Authority of Pakistan (DRAP) - All rights reserved 9

3.3. Licensing Module

Following are all possible license application processing stages:

3.3.1. New License (Company User)

Copyright  Drug Regulatory Authority of Pakistan (DRAP) - All rights reserved 10

Copyright  Drug Regulatory Authority of Pakistan (DRAP) - All rights reserved 11

Copyright  Drug Regulatory Authority of Pakistan (DRAP) - All rights reserved 12

Please see below Figure 4.6 to add above information:

Copyright  Drug Regulatory Authority of Pakistan (DRAP) - All rights reserved 13

Copyright  Drug Regulatory Authority of Pakistan (DRAP) - All rights reserved 14

Copyright  Drug Regulatory Authority of Pakistan (DRAP) - All rights reserved 15

Copyright  Drug Regulatory Authority of Pakistan (DRAP) - All rights reserved 16

Following License could be generated once application is approved by Director after